Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow SNMMI on Twitter
  • Visit SNMMI on Facebook

prostate cancer

  • You have access
    Urokinase-Type Plasminogen Activator Receptor (uPAR) PET/MRI of Prostate Cancer for Noninvasive Evaluation of Aggressiveness: Comparison with Gleason Score in a Prospective Phase 2 Clinical Trial
    Marie Øbro Fosbøl, Sorel Kurbegovic, Helle Hjorth Johannesen, Martin Andreas Røder, Adam Espe Hansen, Jann Mortensen, Annika Loft, Peter Meidahl Petersen, Jacob Madsen, Klaus Brasso and Andreas Kjaer
    Journal of Nuclear Medicine March 1, 2021, 62 (3) 354-359; DOI: https://doi.org/10.2967/jnumed.120.248120
  • You have access
    Matched-pair comparison of 18F-DCFPyL PET/CT and 18F-PSMA-1007 PET/CT in 240 prostate cancer patients; inter-reader agreement and lesion detection rate of suspected lesions
    Maurits Wondergem, Friso M van der Zant, Wouter AM Broos and Remco JJ Knol
    Journal of Nuclear Medicine February 5, 2021, jnumed.120.258574; DOI: https://doi.org/10.2967/jnumed.120.258574
  • You have access
    Diagnostic Value, Oncological Outcomes And Safety Profile Of Image-Guided Surgery Technologies During Robot-Assisted Lymph Node Dissection with Sentinel Node Biopsy For Prostate Cancer.
    Elio Mazzone, Paolo Dell'Oglio, Nikos Grivas, Esther Wit, Maarten Donswijk, Alberto Briganti, Fijs van Leeuwen and Henk van der Poel
    Journal of Nuclear Medicine February 5, 2021, jnumed.120.259788; DOI: https://doi.org/10.2967/jnumed.120.259788
  • You have access
    Synthesis and evaluation of 18F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-18F-fluoro-5α-dihydrotestosterone
    Inês F. Antunes, Rutger Dost, Hilde D. Hoving, Aren van Waarde, Rudi A. Dierckx, Douwe F. Samplonius, Wijnand Helfrich, Philip H Elsinga, Erik F de Vries and Igle J. de Jong
    Journal of Nuclear Medicine January 30, 2021, jnumed.120.253641; DOI: https://doi.org/10.2967/jnumed.120.253641
  • Open Access
    Head-to-head comparison of 68Ga-prostate-specific membrane antigen PET/CT and ferumoxtran-10 enhanced MRI for the diagnosis of lymph node metastases in prostate cancer patients
    Melline GM Schilham, Patrik Zamecnik, Bastiaan M Privé, Bas Israël, Mark Rijpkema, Tom Scheenen, Jelle O Barentsz, James Nagarajah and Martin Gotthardt
    Journal of Nuclear Medicine January 30, 2021, jnumed.120.258541; DOI: https://doi.org/10.2967/jnumed.120.258541
  • You have access
    Salvage Radiotherapy Management Decision in Post-prostatectomy Patients with Recurrent Prostate Cancer Based on 18F-Fluciclovine PET/CT Guidance
    Olayinka A. Abiodun-Ojo, Ashesh B. Jani, Akinyemi A. Akintayo, Oladunni O. Akin-Akintayo, Oluwaseun A. Odewole, Funmilayo Tade, Shreyas S. Joshi, Viraj A. Master, Bridget Fielder, Raghuveer K. Halkar, Chao Zhang, Subir Goyal, Mark M. Goodman and David M. Schuster
    Journal of Nuclear Medicine January 30, 2021, jnumed.120.256784; DOI: https://doi.org/10.2967/jnumed.120.256784
  • You have access
    Standardized Uptake Values are Adequate Measures of Lesional 18F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden.
    Yves Jan Lambert Bodar, Berend Pieter Francis Koene, Bernard H.E. Jansen, Matthijs C.F. Cysouw, Dennie Meijer, Harry N.H. Hendrikse, André N Vis, Ronald Boellaard and Daniela E. Oprea-Lager
    Journal of Nuclear Medicine January 28, 2021, jnumed.120.260232; DOI: https://doi.org/10.2967/jnumed.120.260232
  • Open Access
    Diagnostic Accuracy of 18F-PSMA-1007 PET/CT Imaging for Lymph Node Staging of Prostate Carcinoma in Primary and Biochemical Recurrence
    Katharina Sprute, Vasko Kramer, Stefan A. Koerber, Manuel Meneses, Rene Fernandez, Cristian Soza-Ried, Mathias Eiber, Wolfgang A. Weber, Isabel Rauscher, Kambiz Rahbar, Michael Schaefers, Tadashi Watabe, Motohide Uemura, Sadahiro Naka, Norio Nonomura, Jun Hatazawa, Constantin Schwab, Viktoria Schütz, Markus Hohenfellner, Tim Holland-Letz, Juergen Debus, Clemens Kratochwil, Horacio Amaral, Pete L. Choyke, Uwe Haberkorn, Camilo Sandoval and Frederik L. Giesel
    Journal of Nuclear Medicine February 1, 2021, 62 (2) 208-213; DOI: https://doi.org/10.2967/jnumed.120.246363
  • You have access
    68Ga-PSMA PET/CT for Primary Lymph Node and Distant Metastasis NM Staging of High-Risk Prostate Cancer
    Søren Klingenberg, Mads R. Jochumsen, Benedicte P. Ulhøi, Jacob Fredsøe, Karina D. Sørensen, Michael Borre and Kirsten Bouchelouche
    Journal of Nuclear Medicine February 1, 2021, 62 (2) 214-220; DOI: https://doi.org/10.2967/jnumed.120.245605
  • Immune-Checkpoint Blockade Enhances <sup>225</sup>Ac-PSMA617 Efficacy in a Mouse Model of Prostate Cancer
    You have access
    Immune-Checkpoint Blockade Enhances 225Ac-PSMA617 Efficacy in a Mouse Model of Prostate Cancer
    Johannes Czernin, Kyle Current, Christine E. Mona, Lea Nyiranshuti, Firas Hikmat, Caius G. Radu and Katharina Lückerath
    Journal of Nuclear Medicine February 1, 2021, 62 (2) 228-231; DOI: https://doi.org/10.2967/jnumed.120.246041

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 23
SNMMI

© 2021 Journal of Nuclear Medicine

Powered by HighWire